Showing results (1-10 of 18) with videos related to
Sort By:
Pageof 2
Advances in Experimental Medicine and Biology|November 13, 2012
Tumor dormancy, oncogene addiction, cellular senescence, and self-renewal programsDavid I Bellovin, Bikul Das, Dean W FelsherCurrent Opinion in Immunology|April 11, 2013
Noncanonical roles of the immune system in eliciting oncogene addictionStephanie C Casey, David I Bellovin, Dean W FelsherCancer Research|December 3, 2005
Altered localization of p120 catenin during epithelial to mesenchymal transition of colon carcinoma is prognostic for aggressive diseaseDavid I Bellovin, Richard C Bates, Alona Muzikansky, et al.Plos One|June 19, 2008
Hepatotoxin-induced changes in the adult murine liver promote MYC-induced tumorigenesisShelly Beer, Kimberly Komatsubara, David I Bellovin, et al.Cancer Research|January 26, 2011
MYC phosphorylation, activation, and tumorigenic potential in hepatocellular carcinoma are regulated by HMG-CoA reductaseZhongwei Cao, Hua Fan-Minogue, David I Bellovin, et al.Analytical Chemistry|April 9, 2013
Characterization of MYC-induced tumorigenesis by in situ lipid profilingRichard H Perry, David I Bellovin, Emelyn H Shroff, et al.The Journal of Clinical Investigation|January 26, 2005
Transcriptional activation of integrin beta6 during the epithelial-mesenchymal transition defines a novel prognostic indicator of aggressive colon carcinomaRichard C Bates, David I Bellovin, Courtney Brown, et al.Mabs|November 1, 2021
Preclinical characterization of bemarituzumab, an anti-FGFR2b antibody for the treatment of cancerHong Xiang, Abigael G Chan, Ago Ahene, et al.Plos One|October 2, 2012
SIRT1 and c-Myc promote liver tumor cell survival and predict poor survival of human hepatocellular carcinomasKyu Yun Jang, Sang Jae Noh, Nadja Lehwald, et al.Oncogene|October 7, 2022
MYC oncogene elicits tumorigenesis associated with embryonic, ribosomal biogenesis, and tissue-lineage dedifferentiation gene expression changesDelaney K Sullivan, Anja Deutzmann, Josiah Yarbrough, et al.Pageof 2